Skip to main content

Table 3 Description of symptom scores from; eyes, nose, and lung‡, before and after allergen immunotherapy

From: Treatment with pollen allergen immunotherapy improves health-related quality of life in children and adolescents: a three-year follow-up-study

Symptom from

Base mean (95% CI)

n = 152

Girls, n = 53

Boys, n = 99

Age 5–10, n = 57

Age 11–16, n = 95

One year mean (95% CI)

n = 134

Girls, n = 50

Boys, n = 84

Age 5–10, n = 51

Age 11–16, n = 83

Two years mean (95% CI)

n = 128

Girls, n = 51

Boys, n = 77

Age 5–10, n = 42

Age 11–16, n = 86

Three years mean (95% CI)

n = 85

Girls, n = 29

Boys, n = 56

Age 5–10, n = 33

Age 11–16, n = 52

p value†

Eyes

 All

7.7 (7.2–8.2)

4.2 (3.7–4.6)

4.4 (3.9–5.0)

4.0 (3.4-4.6)

 < 0.001

 Girls

8.4 (7.6–9.1)

4.5 (3.7–5.3)

4.6 (3.8–5.4)

4.6 (3.5–5.7)

 < 0.001

 Boys

7.3 (6.7–8.0)

4.0 (3.4–4.6)

4.3 (3.6–5.0)

3.7 (3.0–4.4)

 < 0.001

 Age 5–10 year

7.3 (6.4–8.1)

3.8 (3.2–4.4)

4.7 (3.8–5.6)

3.8 (2.9–4.7)

 < 0.001

 Age 11–16 year

8.0 (7.4–8.6)

4.4 (3.8–5.1)

4.3 (3.6–4.9)

4.2 (3.4–4.9)

 < 0.001

Nose

 All

7.8 (7.3–8.3)

5.0 (4.6–5.6)

5.0 (4.6–5.6)

4.5 (4.0–5.1)

 < 0.001

 Girls

8.0 (7.3–8.7)

5.5 (4.6–6.3)

5.4 (4.6–6.2)

4.6 (3.6–5.5)

 < 0.001

 Boys

7.7 (7.1–8.4)

4.8 (4.2–5.4)

4.9 (4.2–5.5)

4.5 (3.8–5.2)

 < 0.001

 Age 5–10 year

7.7 (6.9–8.5)

4.2 (3.5–4.9)

4.6 (3.8–5.4)

4.2 (3.3–5.0)

 < 0.001

 Age 11–16 year

7.9 (7.3–8.5)

5.6 (4.9–6.2)

5.3 (4.7–5.9)

4.8 (4.0–5.5)

 < 0.001

Lung

 All

4.3 (3.8–4.7)

2.3 (1.9–2.7)

2.4 (2.0–2.8)

1.7 (1.3–2.1)

 < 0.001

 Girls

4.6 (3.9–5.3)

2.6 (2.0–3.3)

2.6 (1.9–3.3)

1.5 (0.9–2.2)

 < 0.001

 Boys

4.1 (3.5–4.7)

2.1 (1.6–2.6)

2.3 (1.8–2.8)

1.8 (1.3–2.4)

 < 0.001

 Age 5–10 year

4.2 (3.3–5.8)

1.8 (1.2–2.3)

2.2 (1.5–3.0)

1.4 (0.9–2.0)

 < 0.001

 Age 11–16 year

4.3 (3.7–4.9)

2.6 (2.2–3.1)

2.5 (2.0–3.0)

1.9 (1.3–2.4)

 < 0.001

Symptom’s sum

 All

19.9 (19.0–21.0)

11.5 (10.4–12.6)

11.9 (10.7–13.0)

10.3 (8.9–11.6)

 < 0.001

 Girls

21.0 (19.6–22.4)

12.6 (10.7–14.5)

12.5 (10.7–14.4)

10.7 (8.3–13.1)

 < 0.001

 Boys

19.3 (17.9–20.6)

10.8 (9.5–12.2)

11.4 (9.8–13.0)

10.0 (8.3–11.7)

 < 0.001

 Age 5–10 year

19.3 (17.6–20.9)

9.8 (8.3–11.2)

11.4 (9.4–13.5)

9.4 (7.2–11.5)

 < 0.001

 Age 11–16 year

20.2 (19.0–21.5)

12.6 (11.0–14.1)

12.1 (10.6–13.5)

10.8 (9.0–12.7)

 < 0.001

  1. †Repeated measures ANOVA
  2. ‡Eyes scores 0–12, nose scores 0–12, lung scores 0–12, higher score indicates more symptom
Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us